Tidal Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,811
Closed -$884K 930
2021
Q2
$884K Sell
4,811
-2,703
-36% -$464K 0.03% 313
2021
Q1
$1.15M Buy
7,514
+1,942
+35% +$300K 0.05% 173
2020
Q4
$871K Buy
5,572
+1,233
+28% +$158K 0.06% 155
2020
Q3
$497K Sell
4,339
-539
-11% -$58.1K 0.07% 151
2020
Q2
$548K Buy
+4,878
New +$518K 0.07% 152

Other funds holding ALXN

Tidal Investments's ALXN Position: Q3 2021 in Review

Tidal Investments sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,811 shares — an estimated $884K sold.

Tidal Investments first reported a position in ALXN in Q2 2020 and held it in 5 quarters. The position peaked at $1.15M in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Tidal Investments reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Tidal Investments sold 4,811 Alexion Pharmaceuticals shares in Q3 2021, an estimated $884K.
  • Tidal Investments first reported a position in Alexion Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • Tidal Investments's Alexion Pharmaceuticals position peaked at $1.15M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Tidal Investments's 13F filing for Q3 2021, filed 15 Nov 2021.